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Sequence-directed inhibition of
protein synthesis by RNAi has
potential as a means to control
pest wildlife. Species speciﬁc by
design, RNAi reduces impacts on
nontarget species and the environment. Additional research advancing the ﬁeld of RNAi-based
management of vertebrate pest
wildlife is timely.
Plant scientist Richard Jorgensen ﬁrst
described his observation of gene silencing in petunias in the early 1990s. Since
that time, Andrew Fire and Craig Mello
earned a Nobel Prize for their work in
nematodes and coined the phrase RNA
interference. Signiﬁcant effort has been
made in human pharmaceuticals to use
RNAi in the treatment of numerous diseases with the ﬁrst clinical trials for an
RNAi-based human therapeutics coming
only 6 years after its discovery. The appealing attribute of RNAi is that it mediates
sequence-speciﬁc degradation of mRNA.
Therefore, RNAi is used to block the
synthesis of speciﬁc proteins (Box 1).
This is useful for disease treatment, but
also shows promise for the development
of species-speciﬁc toxicants or reproductive inhibitors for the control of animal
species. There has been signiﬁcant progress applying RNAi technology for the
control of insect pests [1,2]; in 2017,
the US Environmental Protection Agency
registered the ﬁrst RNAi-based product
targeting insects. Despite the potential
diverse applications of RNAi technology
in vertebrates for fertility control, invasive
species eradication, and pest species
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management to protect human health the target animal’s genes, reducing risks
and agriculture, little progress has been to nontarget species. To achieve this,
made in applying RNAi to vertebrate con- genes from the target animal are compared with the gene sequences of nontrol.
targets to identify regions of signiﬁcant
Invasive and pest wildlife species cause divergence. RNAi molecules are then designiﬁcant damage to ecosystems and signed to bind those regions of the target
human infrastructure, spoil food stores, animal’s gene (Figure 1). These sequence
and eat or ruin food crops. On average, differences result in a mismatch of the
rodents damage or spoil 10–30% of RNAi and the mRNA of the nontarget
food crops (N77 million tons) annually, animal; this mismatch prevents binding
enough food to feed 180 million people and the subsequent gene silencing. Dif[3]. Mitigating these effects often depends ferences of a single nucleotide have
on controlling animals using chemicals been shown to be sufﬁcient to prevent
in toxic baits or fertility control agents. RNAi binding [5]. RNAi sequences are
Criticism of these control methods is approximately 21 base pairs in length so
often focused on lack of efﬁcacy, risks to the region to which the RNAi is designed
nontarget species, and environmental can be moved down the gene until a reburden. Therefore, the development of gion with no similarity to nontarget spenovel control technologies must be focused cies is found. This enables researchers
on species speciﬁcity and low environ- to develop RNAi molecules that have efmental impact. Sequence-speciﬁc gene fects in target species with no effects in
silencing via RNAi holds promise for nontarget animals even if they are exeffective management of pest wildlife. The posed to RNAi.
silencing of genes using RNAi can be more
cost-effective and humane with fewer non- RNAi in Rodent Eradications on
target effects than current approaches.
Islands
Invasive rats and mice cause signiﬁcant
harm to island ecosystems by damaging
ﬂora and causing the extinction of many
RNAi as Lethal Control
The ability to silence a single gene that is species [6]. Fortunately, after the removal
critical to life shows signiﬁcant potential of invasive rodents, island ecosystems
for the ﬁeld of toxicant development. can ﬂourish; however, these rodent eradiToxicants currently used to control verte- cations rely on the use of anticoagulant
brates often have signiﬁcant effects in rodenticides and therefore pose risks to
nontarget animals [4]. RNAi-based toxi- nontarget species. RNAi-based rodenticants can be designed speciﬁcally to cides would be an important innovation

Box 1. RNAi
RNAi is a biological mechanism that directs the post-transcriptional silencing of protein synthesis. It is an
evolutionarily conserved mechanism in eukaryotes. RNAi is dependent on a protective pathway within cells
that degrades mRNA and is thought to be evolutionarily maintained to protect against viral infections.
Double-stranded RNA (dsRNA) binds to an enzyme called DICER that cleaves the dsRNA into smaller
fragments which are then integrated into the RNA-induced silencing complex (RISC). The RISC complex is
responsible for separating the short dsRNA fragments into single-stranded segments. One of these singlestranded segments is then shuttled to and binds the matching mRNA sequencing that was transcribed from
DNA. The complex formed by the RISC (with fragment of the initial dsRNA) and the mRNA then cleaves and
degrades the mRNA. The gene for which the mRNA coded is, therefore, not synthesized and the gene is
silenced.
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Risks and Beneﬁts
Although RNAi is often grouped together
with gene drives in discussions of risk
[10], there are signiﬁcant differences in
the technologies. Gene drives increase
the frequency of a speciﬁc gene over
time in a population through genetic modiﬁcation that is passed down to offspring
[11]. RNAi molecules do not need to be incorporated into the genome of animals to
be efﬁcacious. Therefore, RNAi does not
genetically modify organisms. This is an
important distinction because the hurdles
of containment associated with genedrive based approaches do not apply.
Risk evaluation for RNAi-based tools
(toxicants or reproductive inhibitors)
could likely follow the current paradigm
for traditional chemical toxicants. That
is, if unpredicted risk from RNAi-based
Trends in Biotechnology
tools is found, they could be removed
Figure 1. Pathway of RNAi Gene Silencing.(i) Double-stranded RNA fragment, 21–23 nucleotides in length from use until mitigation measures or
in the cytoplasm of target cell following directed delivery by carrier molecule. (ii) The guide strand and passenger
further technological advancements are
strand are separated. The passenger strand is discarded. (iii) The guide strand is incorporated into the RNA
induced silencing complex (RISC). (iv) The RISC/guide RNA complex ﬁnds the corresponding target mRNA made. However, if current risk analysis
and binds. (v) mRNA is cleaved and degraded. The protein coded for by that mRNA is not synthesized. This is techniques are to be used, careful selectermed gene silencing. Figure created with BioRender.com.
tion of delivery platforms should be made
as virally vectored RNAi tools may have
and a signiﬁcant advancement for island would be of beneﬁt in the effort to manage different risk proﬁles. The beneﬁts of
eradication efforts [7]. The costs associ- both wild horse and feral dog populations RNAi-based tools are far reaching,
ated with protecting nontarget species without the use of lethal control. RNAi as the risks to the environment and nonfrom harm represent a barrier to imple- could be effective as a reproductive inhibi- target species are minimized, allowing
mentation of eradications on islands tor for the control of feral animals. Silencing for widespread use.
that house some of the world’s most en- the Kiss1 gene using RNAi has shown podangered species. Since RNAi-based ro- tential in initial studies [8,9] and meets Concluding Remarks
denticides would pose little risk to many of the criteria for success. The Despite the potential diverse applications
nontarget species, this technology Kiss1 gene has limited distribution and is of RNAi technology in vertebrates (fertility
would enable rodent eradications on found in tissues involved in reproduction. control, invasive species eradication, and
islands previously deemed to have spe- Animals lacking Kiss1 gene products pest species control to protect human
cies assemblages that were too complex (proteins) are infertile. Introducing RNAi for health and agriculture), little progress has
the Kiss1 gene would block the synthesis been made in applying RNAi to these clasfor cost-effective eradication efforts.
of the kisspeptin protein that is critical to ses of animals. A single proof-of-concept
reproduction. The systemic delivery of study using RNAi to control sea lampreys
RNAi to Disrupt Fertility
Although lethal control using chemical tox- an RNAi-based reproductive inhibitor that combined with recent advances in RNAi
icants is a mainstay for the management of causes permanent sterility would help in delivery have opened the door to numerpest wildlife, inhibiting reproduction may the nonlethal management of many wildlife ous innovative applications of this technolbe an effective means to control popula- species, reducing not only the damage ogy in vertebrate management [12]. One
tions and might be preferred over lethal they may cause to the environment and of the hurdles to further development of
control in some cases. An inexpensive, human infrastructure but also the transmis- RNAi in vertebrates will be delivery. To
facilitate widespread use of RNAi-based
noninvasive method to sterilize animals sion of zoonotic diseases.
Trends in Biotechnology, November 2020, Vol. 38, No. 11
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products, oral baits will likely be necessary. Delivering RNAi orally will face many
challenges, including protection from the
hostile conditions in the gastrointestinal
tract (GI), uptake into the systemic circulation, and shuttling the RNAi to the site of
action. Research in nanotechnology has
led to the development of numerous different nanoparticles that have been shown to
facilitate effective oral delivery and GI uptake [13]. Other scientists are making
progress tackling cellular delivery and internalization using cell-penetrating peptides [14]. Continued research in delivery,
in vivo shuttling, and cell penetration will
be imperative for the success of RNAi
technology in vertebrate pest management applications.
Because they are species-speciﬁc by
design, RNAi-based products reduce risks
to nontarget organisms, enabling them
to be used broadly across landscapes,
even in ecosystems that historically have
been avoided because of environmental
concerns. However, the small segments
of nucleotides that make up RNAi molecules may still be recognized as foreign
by both target and nontarget animals,
thereby eliciting an immune response.
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These possible immune adverse effects
of RNAi will need to be considered during
RNAi development. Advances have been
made toward reducing immune activation
but continued research is important to
ensure low risks to nontarget species
[15]. Another beneﬁt of interfering RNA
is that it does not involve modiﬁcation
of the genome and consequently is not
heritable; therefore, it is free from the
controversy surrounding gene drives.
Continued research in RNAi will provide
breakthrough advancements in tools to
control animal species protecting human
health, agriculture, and infrastructure. Their
use on the landscape level will require
careful development of baits that retain
activity through exposure to the conditions of the GI tract and are stable in
harsh environmental conditions of varying
temperature, humidity, and UV exposure.
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